Even when no artificial intelligence (AI) is watching, writers are rewriting themselves, flattening their voices, policing ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

NPR's Ailsa Chang talks with Shane O'Neill of The Washington Post about the word "aesthetic" and its evolution from art criticism and design theory to online speak and the White House.

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...

This project has not set up a SECURITY.md file yet.